Back to top
more

Ventas (VTR)

(Real Time Quote from BATS)

$61.67 USD

61.67
490,315

+0.55 (0.90%)

Updated Aug 30, 2024 12:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (79 out of 251)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.

How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?

by Zacks Equity Research

Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.

Welltower (WELL) Q4 FFO & Revenues Beat, SHO Occupancy Rises

by Zacks Equity Research

Welltower's (WELL) Q4 results gain on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company issues its 2023 outlook.

Ventas' (VTR) Q4 FFO and Revenues Beat, SHOP NOI Increases

by Zacks Equity Research

Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The SHOP same-store NOI improves on strong pricing power and occupancy growth. It issues 2023 outlook.

Ventas (VTR) Q4 FFO and Revenues Beat Estimates

by Zacks Equity Research

Ventas (VTR) delivered FFO and revenue surprises of 1.39% and 0.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Ventas (VTR)

by Zacks Equity Research

Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Ventas (VTR) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Ventas' (VTR) Q4 earnings are likely to have benefited from the occupancy growth in the SHOP segment. However, higher interest rates and a stronger U.S. dollar might have been a spoilsport.

What's in Store for Healthpeak (PEAK) This Earnings Season?

by Zacks Equity Research

High demand for Healthpeak's (PEAK) life-science assets and rising healthcare spending by senior citizens are likely to have aided its Q4 earnings. Interest rate hikes might have been a deterrent.

Omega Healthcare (OHI) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Rent defaults by some of Omega Healthcare's (OHI) operators facing occupancy and elevated staffing cost pressure, and the firm's restructuring moves might have adversely impacted its Q4 earnings.

Is It Wise to Retain Ventas (VTR) Stock in Your Portfolio?

by Zacks Equity Research

A rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet bode well for Ventas (VTR). Meanwhile, stiff competition and higher interest rates are woes.

Welltower (WELL) Q3 FFO Meets, Revenues Top, Same-Store NOI Up

by Zacks Equity Research

Welltower (WELL) reports healthy Q3 results, with the top line growing year over year. The SHO portfolio witnesses improvement in occupancy. WELL's total same-store NOI increases year over year.

Ventas' (VTR) Q3 FFO Meets, Revenues Beat, SHOP NOI Rises

by Zacks Equity Research

Ventas (VTR) reports better-than-anticipated revenues. The SHOP same-store NOI improves on solid demand and pricing power.

Ventas (VTR) Q3 FFO Meet Estimates

by Zacks Equity Research

Ventas (VTR) delivered FFO and revenue surprises of 0% and 0.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Four Corners Property Trust (FCPT) Q3 FFO Match Estimates

by Zacks Equity Research

Four Corners Property (FCPT) delivered FFO and revenue surprises of 0% and 4.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Vornado (VNO) Q3 FFO and Revenues Beat Estimates

by Zacks Equity Research

Vornado (VNO) delivered FFO and revenue surprises of 9.46% and 5.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

What's in the Offing for Ventas (VTR) This Earnings Season?

by Zacks Equity Research

Ventas' (VTR) Q3 earnings are likely to have benefited from the occupancy growth of its SHOP portfolio. However, elevated expenses and higher interest rates might have been a spoilsport.

Sheraz Mian headshot

Top Stock Reports for Air Products, Southern Copper & Discover Financial

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Air Products and Chemicals, Inc. (APD), Southern Copper Corporation (SCCO) and Discover Financial Services (DFS).

Here's Why You Should Retain Ventas (VTR) in Your Portfolio

by Zacks Equity Research

Rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet will aid Ventas (VTR). Yet, stiff competition and higher interest rates are woes.

Welltower (WELL) Q2 FFO & Revenues Beat, SHOP Occupancy Up

by Zacks Equity Research

Welltower's (WELL) Q2 results outpace estimates with solid top-line growth. The seniors housing operating portfolio occupancy witnesses significant improvements year over year.

Welltower (WELL) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Welltower's (WELL) Q2 earnings are likely to have benefited from occupancy gains in the seniors housing operating portfolio. However, higher expenses in the quarter might have been a deterrent.

Ventas' (VTR) Q2 FFO Meets, Revenues Up Y/Y, SHOP NOI Rises

by Zacks Equity Research

Ventas' (VTR) Q2 results display year-over-year top-line growth aided by solid demand and improving pricing power for the senior housing operating portfolio.

Ventas (VTR) Q2 FFO Meet Estimates

by Zacks Equity Research

Ventas (VTR) delivered FFO and revenue surprises of 0% and 1.92%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

The Necessity Retail (RTL) Q2 FFO and Revenues Beat Estimates

by Zacks Equity Research

The Necessity Retail (RTL) delivered FFO and revenue surprises of 7.41% and 16.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Ventas (VTR) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Ventas' (VTR) Q2 earnings are likely to have benefited from the occupancy growth of its SHOP segment. However, earnings dilution in the triple net and office segments might have been a spoilsport.

Is it Wise to Retain Ventas (VTR) Stock in Your Portfolio?

by Zacks Equity Research

Ventas (VTR) is well-positioned to gain from its diverse healthcare real estate portfolio and a healthy balance-sheet position. Yet, tenant concentration risk and interest rate hikes are major woes.